Clinical Trial Update: Prevention of Cystic Fibrosis Diabetes [Phase 3]

View source ↗

Summary

Emory University's Phase 3 trial aimed at preventing diabetes in people with cystic fibrosis and prediabetes was terminated; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Prediabetes

Snippet

Sponsor: Emory University | Conditions: Cystic Fibrosis, Prediabetes | Phase 3 | Status: TERMINATED | Results posted: 2018-06-25